EBV, Infectious Triggers, and Autoimmune Mechanisms

1 Bu et al. 2024 — EBV as a Potentiator of Autoimmune Diseases

Full Citation:: Bu Y, Shao X, Zhang Y, Wang H, Li F, Hu Y, Liu Z. Epstein-Barr virus as a potentiator of autoimmune diseases. Frontiers in Immunology. 2024;15:1490308. DOI:: 10.3389/fimmu.2024.1490308 PMID:: 39390260 Published:: November 2024 Study Design:: Narrative review Key Findings::

- EBV potentiates autoimmunity through three primary mechanisms: (1) molecular mimicry between EBNA1 and host autoantigens, (2) bystander activation of autoreactive lymphocytes during the viral immune response, (3) epitope spreading following tissue damage
- Adolescent primary EBV infection (infectious mononucleosis) is associated with increased risk for subsequent diagnosis of multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune conditions
- EBV can persist within memory B cells indefinitely, maintaining chronic low-level antigenic stimulation that sustains autoreactive clones
- Timing of infection relative to immune maturation influences long-term autoimmune risk profile

Relevance to ME/CFS:: Supports the EBV-adolescence interaction hypothesis (Hypothesis EBV-Adolescence Autoimmune Window) by documenting that adolescent EBV infection carries elevated autoimmune risk compared to childhood infection. Consistent with documented GPCR autoantibodies in ME/CFS patients and the post-mononucleosis onset pattern. Molecular mimicry mechanisms provide a plausible pathway by which self-reactive B cells generated during primary EBV infection persist beyond viral clearance. Certainty Assessment::

- *Quality:* Medium (Frontiers in Immunology; peer-reviewed narrative review; broad scope)
- *Study type:* Narrative review; no systematic search protocol reported
- *Limitations:* Susceptible to selection bias; causal claims are better established for MS than for ME/CFS; ME/CFS not directly discussed
- *Convergence:* Consistent with Munir et al.\ 2025 and the foundational Ascherio 2022 *Science* paper establishing EBV as necessary antecedent for multiple sclerosis

2 Munir et al. 2025 — EBV Molecular Mimicry in Autoimmune Disease

Full Citation:: Munir H, Jamshed A, Khan S, Ahmed B. The Role of Epstein-Barr Virus Molecular Mimicry in Various Autoimmune Diseases. Scandinavian Journal of Immunology. 2025;103(1):e70016. DOI:: 10.1111/sji.70016 Published:: January 2025 Study Design:: Narrative review Key Findings::

- EBNA1 (EBV nuclear antigen 1) contains sequences that mimic epitopes on human autoantigens including histones, myelin basic protein, and nuclear proteins
- Adolescent primary EBV infection causes infectious mononucleosis in 35–50% of cases, substantially higher than the typically asymptomatic rate in childhood infection
- Three molecular pathways: (1) EBNA1-mediated molecular mimicry generating cross-reactive autoantibodies, (2) bystander activation of latent autoreactive lymphocytes, (3) epitope spreading following tissue damage
- EBV-driven polyclonal B cell activation generates autoantibody responses that can persist after viral control

Relevance to ME/CFS:: Documents the mechanistic basis for why adolescent EBV infection may trigger persistent autoimmune sequelae. The 35–50% IM rate in adolescent primary infection (versus asymptomatic in children) is cited in the EBV-adolescence speculation to explain age-dependent ME/CFS risk following mononucleosis. Certainty Assessment::

- *Quality:* Medium (Scandinavian Journal of Immunology; peer-reviewed)
- *Study type:* Narrative review
- *Limitations:* Mechanistic pathways well-established for MS and SLE but not directly studied in ME/CFS; extrapolation to GPCR autoantibody generation is inferential
- *Convergence:* Consistent with Bu et al.\ 2024 and Pless et al.\ 2026

3 Pless et al. 2026 — EBV LMP1 and CNS Demyelination

Full Citation:: Pless A, et al. Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formation. Cell. 2026;January. DOI:: 10.1016/j.cell.2025.12.031 Published:: January 2026 Study Design:: Mechanistic preclinical study Key Findings::

- B cells expressing EBV's latent membrane protein 1 (LMP1) can capture myelin antigens within the CNS
- LMP1-expressing B cells that have captured myelin antigens provoke demyelinating lesion formation — a direct cellular mechanism distinct from earlier molecular mimicry models
- Demonstrates that EBV-infected B cells, upon penetrating the blood-brain barrier, can directly initiate CNS autoimmune pathology

Relevance to ME/CFS:: Extends the EBV-neuroinflammation connection to a direct cellular mechanism. If EBV-infected B cells enter the CNS and initiate local immune reactions, this could contribute to the neuroinflammation documented in ME/CFS (Nakatomi 2014). LMP1 expression is particularly prominent during primary infection, making this mechanism most relevant to adolescent EBV-triggered ME/CFS. Certainty Assessment::

- *Quality:* High (*Cell*; premier peer-reviewed journal)
- *Study type:* Preclinical mechanistic study; January 2026 — very recent; independent replication pending
- *Limitations:* Mechanism demonstrated specifically for demyelination; whether the same process applies to ME/CFS neuroinflammation (microglial activation without overt demyelination) is not established